0.82 AnaptysBio (NASDAQ:ANAB) shareholders have endured a 66% loss from investing in the stock five years ago

News


<< back

AnaptysBio (NASDAQ:ANAB) shareholders have endured a 66% loss from investing in the stock five years ago
Date: 2023-12-27 [news.yahoo.com]

READ THE FULL NEWS >>
×